register

News & Trends - Pharmaceuticals

AMA, RACGP and Medicines Australia mourn the sad loss of Dr Harry Nespolon

Health Industry Hub | July 28, 2020 |

Pharma News: The AMA joins with the Royal Australian College of General Practice (RACGP), Medicines Australia and the wider medical community in mourning the sad loss of RACGP President, Dr Harry Nespolon following a battle with pancreatic cancer.

AMA President Dr Tony Bartone, who is also a member of the RACGP, said that Dr Nespolon would be sorely missed across General Practice.

“I’ve worked alongside Harry in advocacy for General Practice, for the medical profession, and our patients for years,” Dr Bartone said.

“Harry was a great defender of General Practice. He stood up for doctors. He and I spent many hours working with government officials to improve our health care system for the better. He simply was passionate about his patients and their care.

“Even during the final stages of his illness, Harry kept working full pace on behalf of General Practitioners.

“Indeed; in the last few months, my interactions with Harry augmented significantly in proportion to the enormous policy settings in discussion around General Practice. He always was present.

“Harry will be sorely missed, and I offer the condolences of all at the AMA to the Nespolon family and our RACGP colleagues,” Dr Bartone said.

Dr Nespolon has made an immense contribution to Medicines Australia and to the industry. He has been a valuable member of the Medicines Australia Code of Conduct Committee for over 15 years. Dr Nespolon’s unfailing determination to uphold ethical behaviour, along with his ability to make rational decisions, quickly made him an integral part of the Committee. Never afraid to make a statement, or ask a challenging question, Dr Nespolon’s contribution to this committee will be sorely missed.

According to Medicines Australia, Dr Nespolon showed great leadership of the RACGP during the COVID-19 Crisis. His tireless work advocating for continuity of care, and strong criticism of misinformation being spread demonstrated his passion for his profession.

In addition to his role as RACGP President, Dr Nespolon made a significant contribution to the wider health system through his participation in a number of organisations that covered General Practice training, primary care and the hospital sector.

Dr Nespolon also worked for a period at the AMA Federal Secretariat in the 1990s.


News & Trends - Pharmaceuticals

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Health Industry Hub | March 14, 2025 |

Over a third of Australian adults live with obesity, and the National Obesity Strategy estimates the direct and indirect costs […]

More


News & Trends - Pharmaceuticals

Astellas secures new indication for prostate cancer drug

Astellas secures new indication for prostate cancer drug

Health Industry Hub | March 14, 2025 |

Astellas Xtandi (enzalutamide) is now TGA registered for a new indication for patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with […]

More


News & Trends - MedTech & Diagnostics

Stakeholder calls intensify as government stalls on genetic discrimination ban

Stakeholder calls intensify as government stalls on genetic discrimination ban

Health Industry Hub | March 14, 2025 |

Calls have intensified for the federal government to honour its commitment to outlaw genetic discrimination in life insurance, as stakeholders […]

More


News & Trends - MedTech & Diagnostics

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Health Industry Hub | March 13, 2025 |

As Australia marks World Kidney Day, the stark reality is that one in three adults is at risk of chronic […]

More


This content is copyright protected. Please subscribe to gain access.